Lakshmi Magavi, MD
Obstetrics & Gynecology · Hartford, CTNPI 1538397559
Payments from drug & device makers
Across 101 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$302
- AbbVie$243
- Exeltis, USA Inc.$192
- Sumitomo Pharma America, Inc.$150
- Sage Therapeutics, LLC$147
- Astellas Pharma US Inc$111
- plus $819 from 19 others
What the payments were for
- Food & beverage$1,90697%
- Education$603%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 13 | $302 |
| AbbVie(2 entities) | 14 | $243 |
| Exeltis, USA Inc. | 10 | $192 |
| Sumitomo Pharma America, Inc. | 7 | $150 |
| Sage Therapeutics, LLC | 6 | $147 |
| Astellas Pharma US Inc | 5 | $111 |
| Coopersurgical, Inc. | 4 | $95 |
| Avion Pharmaceuticals | 7 | $91 |
| Pfizer | 4 | $71 |
| Merck | 4 | $71 |
| Bayer | 3 | $65 |
| Organon | 3 | $55 |
| Therapeuticsmd, Inc. | 3 | $52 |
| Exact Sciences | 2 | $49 |
| Millicent US Inc | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
| Hologic Sales And Service, LLC | 2 | $37 |
| Myovant Sciences Inc. | 2 | $37 |
| AMAG Pharmaceuticals, Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Lupin Inc. | 1 | $17 |
| Eisai Inc. | 1 | $14 |
| Medicem Inc. | 1 | $14 |
| Minerva Surgical, Inc | 1 | $14 |
| Unified Women's Healthcare, LP | 1 | $0 |
How this compares
$1,965 in reported general payments places this provider in the 80th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 53 | $3,825 |
| YuvafemEstradiol | 19 | $3,212 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $378 |
| Clobetasol Propionate | 21 | $327 |
| ValacyclovirValacyclovir Hcl | 18 | $237 |
| Fluconazole | 15 | $31 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Hartford
- Alan FineHartford$974K
- Frederick RauHartford$89K
- Adam SteinbergHartford$23K
- Theodoros KapetanakisHartford$7K
- Michael BourqueHartford$4K
- Alessandro SantinNew Haven$14.1M
- Mark LeondiresNorwalk$1.4M
- Mary MinkinNew Haven$285K
- Elena RatnerNew Haven$119K
- Daniel WellingManchester$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.